Recommendations for prevention of neonatal ophthalmia. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
Without preventive measures, gonococcal ophthalmia will develop in approximately 28% of infants born to women with gonorrhea, a disease that is relatively frequent and largely asymptomatic in pregnant women. In addition, in some settings conjunctivitis caused by Chlamydia trachomatis may be more frequent than gonococcal conjunctivitis among neonates. The Canadian Paediatric Society therefore recommends that, as soon as possible after birth, all infants receive prophylaxis with silver nitrate, tetracycline or erythromycin, administered according to specific guidelines.
D003235:Conjunctivitis, Inclusion / Q000517:prevention & control; D004917:Erythromycin / Q000008:administration & dosage; D005260:Female; D006069:Gonorrhea / Q000188:drug therapy; D006801:Humans; D007231:Infant, Newborn; D009824:Ointments; D009878:Ophthalmia Neonatorum / Q000517:prevention & control*; D009883:Ophthalmic Solutions; D010400:Penicillin G / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D012835:Silver Nitrate / Q000008:administration & dosage; D013752:Tetracycline / Q000008:administration & dosage
D009824:Ointments; D009883:Ophthalmic Solutions; D004917:Erythromycin; D012835:Silver Nitrate; D013752:Tetracycline; D010400:Penicillin G